Cargando…
Hyperthermia ablation combined with transarterial chemoembolization versus monotherapy for hepatocellular carcinoma: A systematic review and meta‐analysis
BACKGROUND AND AIMS: The existing evidence has indicated that hyperthermia ablation (HA) and HA combined with transarterial chemoembolization (HATACE) are the optimal alternative to surgical resection for patients with hepatocellular carcinoma (HCC) in the COVID‐19 crisis. However, the evidence for...
Autores principales: | Li, Zheng, Li, Qiang, Wang, Xiaohu, Chen, Weiqiang, Jin, Xiaodong, Liu, Xinguo, Ye, Fei, Dai, Zhongying, Zheng, Xiaogang, Li, Ping, Sun, Chao, Liu, Xiongxiong, Zhang, Qiuning, Luo, Hongtao, Liu, Ruifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633247/ https://www.ncbi.nlm.nih.gov/pubmed/34655179 http://dx.doi.org/10.1002/cam4.4350 |
Ejemplares similares
-
Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis
por: Li, Zheng, et al.
Publicado: (2021) -
Addition of Camrelizumab to Transarterial Chemoembolization in
Hepatocellular Carcinoma With Untreatable Progression
por: Ren, Yanqiao, et al.
Publicado: (2022) -
Liver resection versus transarterial chemoembolization for the treatment of intermediate‐stage hepatocellular carcinoma
por: Chen, Shuling, et al.
Publicado: (2019) -
Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Retrospective Study
por: Tang, Chengwu, et al.
Publicado: (2016) -
Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
por: Duan, Feng, et al.
Publicado: (2020)